342 related articles for article (PubMed ID: 17676995)
1. Molecular basis of resistance to muramidase and cationic antimicrobial peptide activity of lysozyme in staphylococci.
Herbert S; Bera A; Nerz C; Kraus D; Peschel A; Goerke C; Meehl M; Cheung A; Götz F
PLoS Pathog; 2007 Jul; 3(7):e102. PubMed ID: 17676995
[TBL] [Abstract][Full Text] [Related]
2. Why are pathogenic staphylococci so lysozyme resistant? The peptidoglycan O-acetyltransferase OatA is the major determinant for lysozyme resistance of Staphylococcus aureus.
Bera A; Herbert S; Jakob A; Vollmer W; Götz F
Mol Microbiol; 2005 Feb; 55(3):778-87. PubMed ID: 15661003
[TBL] [Abstract][Full Text] [Related]
3. Bacillus subtilis σ(V) confers lysozyme resistance by activation of two cell wall modification pathways, peptidoglycan O-acetylation and D-alanylation of teichoic acids.
Guariglia-Oropeza V; Helmann JD
J Bacteriol; 2011 Nov; 193(22):6223-32. PubMed ID: 21926231
[TBL] [Abstract][Full Text] [Related]
4. Understanding the Structure-Function Relationship of Lysozyme Resistance in Staphylococcus aureus by Peptidoglycan O-Acetylation Using Molecular Docking, Dynamics, and Lysis Assay.
Pushkaran AC; Nataraj N; Nair N; Götz F; Biswas R; Mohan CG
J Chem Inf Model; 2015 Apr; 55(4):760-70. PubMed ID: 25774564
[TBL] [Abstract][Full Text] [Related]
5. The presence of peptidoglycan O-acetyltransferase in various staphylococcal species correlates with lysozyme resistance and pathogenicity.
Bera A; Biswas R; Herbert S; Götz F
Infect Immun; 2006 Aug; 74(8):4598-604. PubMed ID: 16861647
[TBL] [Abstract][Full Text] [Related]
6. The extracytoplasmic function sigma factor SigV plays a key role in the original model of lysozyme resistance and virulence of Enterococcus faecalis.
Le Jeune A; Torelli R; Sanguinetti M; Giard JC; Hartke A; Auffray Y; Benachour A
PLoS One; 2010 Mar; 5(3):e9658. PubMed ID: 20300180
[TBL] [Abstract][Full Text] [Related]
7. Enterococcus faecalis constitutes an unusual bacterial model in lysozyme resistance.
Hébert L; Courtin P; Torelli R; Sanguinetti M; Chapot-Chartier MP; Auffray Y; Benachour A
Infect Immun; 2007 Nov; 75(11):5390-8. PubMed ID: 17785473
[TBL] [Abstract][Full Text] [Related]
8. Influence of wall teichoic acid on lysozyme resistance in Staphylococcus aureus.
Bera A; Biswas R; Herbert S; Kulauzovic E; Weidenmaier C; Peschel A; Götz F
J Bacteriol; 2007 Jan; 189(1):280-3. PubMed ID: 17085565
[TBL] [Abstract][Full Text] [Related]
9. The Staphylococcus aureus two-component regulatory system, GraRS, senses and confers resistance to selected cationic antimicrobial peptides.
Yang SJ; Bayer AS; Mishra NN; Meehl M; Ledala N; Yeaman MR; Xiong YQ; Cheung AL
Infect Immun; 2012 Jan; 80(1):74-81. PubMed ID: 21986630
[TBL] [Abstract][Full Text] [Related]
10. The Bacillus subtilis extracytoplasmic function σ factor σ(V) is induced by lysozyme and provides resistance to lysozyme.
Ho TD; Hastie JL; Intile PJ; Ellermeier CD
J Bacteriol; 2011 Nov; 193(22):6215-22. PubMed ID: 21856855
[TBL] [Abstract][Full Text] [Related]
11. Improved antimicrobial activity of h-lysozyme (107-115) by rational Ala substitution.
González R; Albericio F; Cascone O; Iannucci NB
J Pept Sci; 2010 Aug; 16(8):424-9. PubMed ID: 20582913
[TBL] [Abstract][Full Text] [Related]
12. Transcriptome analysis of the responses of Staphylococcus aureus to antimicrobial peptides and characterization of the roles of vraDE and vraSR in antimicrobial resistance.
Pietiäinen M; François P; Hyyryläinen HL; Tangomo M; Sass V; Sahl HG; Schrenzel J; Kontinen VP
BMC Genomics; 2009 Sep; 10():429. PubMed ID: 19751498
[TBL] [Abstract][Full Text] [Related]
13. Modification of lysozyme with oleoyl chloride for broadening the antimicrobial specificity.
Evran S; Yasa I; Telefoncu A
Prep Biochem Biotechnol; 2010; 40(4):316-25. PubMed ID: 21108135
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides.
Peschel A; Otto M; Jack RW; Kalbacher H; Jung G; Götz F
J Biol Chem; 1999 Mar; 274(13):8405-10. PubMed ID: 10085071
[TBL] [Abstract][Full Text] [Related]
15. Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus.
Meehl M; Herbert S; Götz F; Cheung A
Antimicrob Agents Chemother; 2007 Aug; 51(8):2679-89. PubMed ID: 17502406
[TBL] [Abstract][Full Text] [Related]
16. The GraRS regulatory system controls Staphylococcus aureus susceptibility to antimicrobial host defenses.
Kraus D; Herbert S; Kristian SA; Khosravi A; Nizet V; Götz F; Peschel A
BMC Microbiol; 2008 Jun; 8():85. PubMed ID: 18518949
[TBL] [Abstract][Full Text] [Related]
17. The Cationic Antimicrobial Peptide Activity of Lysozyme Reduces Viable
Rouchon CN; Harris J; Zubair-Nizami Z; Weinstein AJ; Roky M; Frank KL
Antimicrob Agents Chemother; 2022 May; 66(5):e0233921. PubMed ID: 35446133
[TBL] [Abstract][Full Text] [Related]
18. Characterization of O-acetylation of N-acetylglucosamine: a novel structural variation of bacterial peptidoglycan.
Bernard E; Rolain T; Courtin P; Guillot A; Langella P; Hols P; Chapot-Chartier MP
J Biol Chem; 2011 Jul; 286(27):23950-8. PubMed ID: 21586574
[TBL] [Abstract][Full Text] [Related]
19. Characterization of bioactive recombinant antimicrobial peptide parasin I fused with human lysozyme expressed in the yeast Pichia pastoris system.
Zhao H; Tang J; Cao L; Jia G; Long D; Liu G; Chen X; Cai J; Shang H
Enzyme Microb Technol; 2015 Sep; 77():61-7. PubMed ID: 26138401
[TBL] [Abstract][Full Text] [Related]
20. A novel antimicrobial peptide derived from fish goose type lysozyme disrupts the membrane of Salmonella enterica.
Kumaresan V; Bhatt P; Ganesh MR; Harikrishnan R; Arasu M; Al-Dhabi NA; Pasupuleti M; Marimuthu K; Arockiaraj J
Mol Immunol; 2015 Dec; 68(2 Pt B):421-33. PubMed ID: 26477736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
